Latest Insider Transactions at Chemours CO (CC)
This section provides a real-time view of insider transactions for Chemours CO (CC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Chemours Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Chemours Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2022
|
Camela Wisel VP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,154
+9.6%
|
-
|
Mar 01
2022
|
Camela Wisel VP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-5.14%
|
$13,150
$25.98 P/Share
|
Mar 01
2022
|
Alisha Bellezza President, Thermal Spec Solns |
BUY
Grant, award, or other acquisition
|
Direct |
21,362
+21.12%
|
-
|
Mar 01
2022
|
Alisha Bellezza President, Thermal Spec Solns |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-5.15%
|
$24,600
$25.98 P/Share
|
Mar 01
2022
|
Guillaume Pepy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,395
+50.0%
|
-
|
Mar 01
2022
|
Susan M. Kelliher SVP, People and Health Service |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+5.79%
|
-
|
Mar 01
2022
|
Susan M. Kelliher SVP, People and Health Service |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-0.77%
|
$8,000
$25.98 P/Share
|
Mar 01
2022
|
Edwin C Sparks President, Titan Tech Chem Sol |
BUY
Grant, award, or other acquisition
|
Direct |
4,234
+4.05%
|
-
|
Mar 01
2022
|
Edwin C Sparks President, Titan Tech Chem Sol |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-0.43%
|
$10,325
$25.98 P/Share
|
Feb 11
2022
|
Mark Newman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,133
-4.32%
|
$213,990
$30.0 P/Share
|
Feb 11
2022
|
Mark Newman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,473
+10.56%
|
-
|
Feb 11
2022
|
Susan M. Kelliher SVP, People and Health Service |
SELL
Payment of exercise price or tax liability
|
Direct |
1,928
-4.44%
|
$57,840
$30.0 P/Share
|
Feb 11
2022
|
Susan M. Kelliher SVP, People and Health Service |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+11.1%
|
-
|
Feb 11
2022
|
David C Shelton SVP, GC & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,933
-4.21%
|
$87,990
$30.0 P/Share
|
Feb 11
2022
|
David C Shelton SVP, GC & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,578
+10.95%
|
-
|
Feb 11
2022
|
Edwin C Sparks President, Titan Tech Chem Sol |
SELL
Payment of exercise price or tax liability
|
Direct |
3,112
-3.12%
|
$93,360
$30.0 P/Share
|
Feb 11
2022
|
Edwin C Sparks President, Titan Tech Chem Sol |
BUY
Grant, award, or other acquisition
|
Direct |
9,155
+8.42%
|
-
|
Feb 11
2022
|
Sameer Ralhan SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,975
-1.28%
|
$119,250
$30.0 P/Share
|
Feb 11
2022
|
Sameer Ralhan SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,864
+3.67%
|
-
|
Feb 11
2022
|
Jonathan Lock SVP, Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,016
-14.68%
|
$60,480
$30.0 P/Share
|
Feb 11
2022
|
Jonathan Lock SVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,673
+29.24%
|
-
|
Feb 11
2022
|
Mark P Vergnano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
16,694
-8.79%
|
$500,820
$30.0 P/Share
|
Feb 11
2022
|
Mark P Vergnano Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,564
+21.02%
|
-
|
Dec 02
2021
|
Mark Newman President and CEO |
SELL
Open market or private sale
|
Direct |
34,252
-19.06%
|
$993,308
$29.94 P/Share
|
Dec 02
2021
|
Mark Newman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,252
+16.01%
|
$616,536
$18.45 P/Share
|
Dec 02
2021
|
Sameer Ralhan SVP, CFO |
SELL
Open market or private sale
|
Direct |
17,482
-5.52%
|
$506,978
$29.85 P/Share
|
Dec 02
2021
|
Sameer Ralhan SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,482
+5.23%
|
$314,676
$18.45 P/Share
|
Dec 02
2021
|
David C Shelton SVP, GC & Corp. Secretary |
SELL
Open market or private sale
|
Direct |
9,886
-10.88%
|
$286,694
$29.74 P/Share
|
Dec 02
2021
|
David C Shelton SVP, GC & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
9,886
+9.81%
|
$177,948
$18.45 P/Share
|
Dec 02
2021
|
Mark P Vergnano Director |
SELL
Open market or private sale
|
Direct |
99,968
-41.85%
|
$2,899,072
$29.92 P/Share
|
Dec 02
2021
|
Mark P Vergnano Director |
BUY
Exercise of conversion of derivative security
|
Direct |
99,968
+29.5%
|
$1,799,424
$18.45 P/Share
|
Oct 26
2021
|
Sandra Phillips Rogers Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,008
+50.0%
|
-
|
Aug 30
2021
|
Mark Newman President and CEO |
SELL
Open market or private sale
|
Direct |
3,691
-2.48%
|
$129,185
$35.0 P/Share
|
Aug 30
2021
|
Mark Newman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,691
+2.42%
|
$66,438
$18.45 P/Share
|
Aug 30
2021
|
Sameer Ralhan SVP, CFO |
SELL
Open market or private sale
|
Direct |
1,890
-0.63%
|
$66,150
$35.0 P/Share
|
Aug 30
2021
|
Sameer Ralhan SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,890
+0.62%
|
$34,020
$18.45 P/Share
|
Aug 30
2021
|
David C Shelton SVP, GC & Corp. Secretary |
SELL
Open market or private sale
|
Direct |
1,065
-1.64%
|
$37,275
$35.0 P/Share
|
Aug 30
2021
|
David C Shelton SVP, GC & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,065
+1.61%
|
$19,170
$18.45 P/Share
|
Aug 30
2021
|
Mark P Vergnano Director |
SELL
Open market or private sale
|
Direct |
10,793
-3.21%
|
$377,755
$35.0 P/Share
|
Aug 30
2021
|
Mark P Vergnano Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,793
+3.11%
|
$194,274
$18.45 P/Share
|
Aug 27
2021
|
Sameer Ralhan SVP, CFO |
SELL
Open market or private sale
|
Direct |
15,085
-4.81%
|
$527,975
$35.0 P/Share
|
Aug 27
2021
|
Sameer Ralhan SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,085
+4.59%
|
$271,530
$18.45 P/Share
|
Aug 27
2021
|
Mark Newman President and CEO |
SELL
Open market or private sale
|
Direct |
29,732
-16.98%
|
$1,040,620
$35.0 P/Share
|
Aug 27
2021
|
Mark Newman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,732
+14.51%
|
$535,176
$18.45 P/Share
|
Aug 27
2021
|
David C Shelton SVP, GC & Corp. Secretary |
SELL
Open market or private sale
|
Direct |
8,689
-11.97%
|
$304,115
$35.0 P/Share
|
Aug 27
2021
|
David C Shelton SVP, GC & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
8,689
+10.69%
|
$156,402
$18.45 P/Share
|
Aug 27
2021
|
Mark P Vergnano Director |
SELL
Open market or private sale
|
Direct |
87,360
-21.16%
|
$3,057,600
$35.0 P/Share
|
Aug 27
2021
|
Mark P Vergnano Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,360
+17.46%
|
$1,572,480
$18.45 P/Share
|
Aug 03
2021
|
Denise Dignam President & CEO |
SELL
Open market or private sale
|
Direct |
5,571
-28.92%
|
$183,843
$33.86 P/Share
|
Aug 03
2021
|
Denise Dignam President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,571
+22.43%
|
$77,994
$14.43 P/Share
|